The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
53BP1 controls a specialized non-homologous end joining (NHEJ) pathway that is essential for adaptive immunity, yet oncogenic in BRCA1 mutant cancers. Intra-chromosomal DNA double-strand break (DSB) joining events during immunoglobulin class switch recombination (CSR) require 53BP1. However, in BRCA...
Principais autores: | Becker, JR, Cuella-Martin, R, Barazas, M, Liu, R, Oliveira, C, Oliver, AW, Bilham, K, Holt, AB, Blackford, AN, Heierhorst, J, Jonkers, J, Rottenberg, S, Chapman, JR |
---|---|
Formato: | Journal article |
Publicado em: |
Springer Nature
2018
|
Registros relacionados
-
53BP1 integrates DNA repair and p53-dependent cell fate decisions via distinct mechanisms
por: Cuella-Martin, R, et al.
Publicado em: (2016) -
53BP1 cooperation with the REV7–shieldin complex underpins DNA structure-specific NHEJ
por: Ghezraoui, H, et al.
Publicado em: (2018) -
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells
por: Schoonen, P, et al.
Publicado em: (2017) -
Molecular regulation of p53-dependent tumour suppressor responses by the p53 binding protein 1
por: Cuella-Martin, R
Publicado em: (2018) -
RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection.
por: Chapman, R, et al.
Publicado em: (2013)